Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 3)

NCT: NCT07772349 · NOT_YET_RECRUITING

NCT IDNCT07772349
StatusNOT_YET_RECRUITING
Start Date2026-10-01
Completion2029-05-01
SponsorThe University of Texas Health Science Center, Houston (OTHER)
First posted
Last updated

Brief Summary

The aim of the study is to assess the treatment effects of deep active repetitive transcranial magnetic stimulation (rTMS) with H4 coil combined with cognitive training for improving frontal white matter microstructural integrity in patients with schizophrenia spectrum disorder (SSD).

Frequently Asked Questions

What is Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 3)?

Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 3) is a clinical trial registered under NCT07772349. Current status: NOT_YET_RECRUITING.

What is the status of NCT07772349?

The current status of NCT07772349 (Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 3)) is: NOT_YET_RECRUITING.

When did Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 3) start?

Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 3) started on 2026-10-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑